Skip to main content
Supplement ScienceSupplementScience

Pygeum Dosage Guide

Evidence:Strong
·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

General Dosage

100-200mg standardized bark extract daily (standardized to 14% triterpenes)

Maximum dose: 200mg daily; most clinical trials use 100mg daily (50mg twice daily)

Dosage Recommendations

General recommendation: 100-200mg standardized bark extract daily (standardized to 14% triterpenes)

Timing: Morning and evening with meals; the twice-daily regimen (50mg x 2) is used in most European clinical protocols • Take with food for best absorption.

Dosage by Condition

BPH urinary symptoms
100mg daily or 50mg twice dailyStrong
Nocturia reduction
100-200mg dailyStrong
Prostate health maintenance
50-100mg dailyModerate

Upper limit: 200mg daily; most clinical trials use 100mg daily (50mg twice daily)

Timing & Absorption

Morning and evening with meals; the twice-daily regimen (50mg x 2) is used in most European clinical protocols

Best taken with food for optimal absorption.

Find a Pygeum with the right dose
We verify actual dosage against clinical research
Full Pygeum Guide

References

  1. Meta-analysisWilt T, Ishani A, Mac Donald R, Rutks I, Stark G (2002). Pygeum africanum for benign prostatic hyperplasia. Cochrane Database of Systematic Reviews. DOI PubMed
  2. ReviewEdgar AD, Levin R, Constantinou CE, Denis L (2007). A critical review of the pharmacology of the plant extract of Pygeum africanum in the treatment of LUTS. Neurourology and Urodynamics. DOI PubMed
  3. Meta-analysisIshani A, MacDonald R, Nelson D, Rutks I, et al. (2000). Pygeum africanum for the treatment of patients with benign prostatic hyperplasia: a systematic review and quantitative meta-analysis.. The American journal of medicine. DOI PubMed
  4. RCTPiquero-Casals J, Saceda-Corralo D, Aladren S, Bustos J, et al. (2025). Oral Supplementation with l-Cystine, Serenoa repens, Cucurbita pepo, and Pygeum africanum in Chronic Telogen Effluvium and Androgenetic Alopecia: A Double-Blind, Placebo-Controlled, Randomized Clinical Study.. Skin appendage disorders. DOI PubMed
  5. ReviewDreikorn K, Berges R, Pientka L, Jonas U (2002). [Phytotherapy of benign prostatic hyperplasia. Current evidence-based evaluation].. Der Urologe. Ausg. A. DOI PubMed
  6. Dreikorn K (2000). Phytotherapeutic agents in the treatment of benign prostatic hyperplasia.. Current urology reports. DOI PubMed